Clinical experience with the intrauterine progesterone contraceptive system
Pharriss, B.B.
Journal of Reproductive Medicine 20(3): 155-165
1978
ISSN/ISBN: 0024-7758 PMID: 641909 Document Number: 3884
The IPCS has been shown to be a safe and highly effective form of contraception with unique actions that stem from the use of progesterone as the active pharmacologic agent. This contraceptive modality, however, carries some of the same risks as do other forms of intrauterine contraception. Judicious selecting, preparing and counseling of the patient will contribute to its successful use. Support and encouragement are essential for patients using IUDs, in the case of a contraceptive such as IPCS, which is new to the physician as well as to the patient. Thus, the preinsertion and first postinsertion visits are important. The postinsertion visit provides an opportunity not only to check on possible problems that can occur in the early months but also to give the patient additional information and support. Reassurance can be very valuable to her at this juncture because she may be at the point at which any initial spotting/bleeding problems are diminishing or about to diminish. Since these symptoms do tend to wane with use (Figures 9, 10, 11 and 12), we feel that the physician is justified in encouraging patients with nuisance-type problems of this kind to persevere with the system for several months. Many will become successful and satisfied users.
Document emailed within 1 workday
